Skip to main content

A Case in Contrasts: How Should the Media Talk About Cancer Diagnoses?

Only a week ago, transatlantic media coverage of the British monarchy quickly pivoted from discussions about photo editing to discussions about adjuvant chemotherapy when Catherine, Princess of Wales revealed that she had been diagnosed with cancer (Kwai, 2024). Since then, many media outlets have raced to interview oncologists about her case and expected recovery. One prominent US oncologist noted on social media, for example, that she had received 4 separate media requests within hou...

A 2024 Kickoff Message From Dr. Rahul Banerjee, Editor in Chief

Many of us are ushering in the New Year singing "Auld Lang Syne" (or some version of those lyrics) with an eye toward ensuring that old acquaintances never be forgotten. Conversely, as we ring in 2024, it's worth noting how many of our old-acquaintance oncology drugs have actually remained at our side. Pembrolizumab was first approved in September 2014 for metastatic melanoma, while blinatumomab was first approved in December 2014 for B-cell acute lymphoblastic leukemia (ALL). (Feel old yet?) No...

A Letter to Oncology Data Advisor Readers From Rahul Banerjee, MD, FACP, and Thomas Abrams, MD

Oncology Data Advisor is excited to announce that Rahul Banerjee, MD, FACP, has been appointed the new Editor in Chief. Dr. Banerjee, an Assistant Professor of Medicine in the Division of Oncology at the University of Washington, Fred Hutchinson Cancer Center, has taken over the role from Thomas Abrams, MD, Assistant Professor of Medicine at Harvard Medical School, who has served in the role since 2021. They are both excited about the transition and have written brief outro and intro letter...